Takeda inks strategic partnership with Covance, Quintiles
Covance and Quintiles will work in close partnership with Takeda to plan and execute global development programs which will support new compounds in all therapeutic areas, except oncology.
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
Pfenex Expression Technology platform is based on the microorganism, Pseudomonas fluorescens, for the production of research proteins, reagent proteins, biosimilars and innovator biopharmaceuticals. Under the multi-year agreement, Pfenex
The Microcyn Technology platform is used to manufacture tissue care products which reduce the need for antibiotics while reducing infections and accelerating healing. The Microcyn Technology features a
Vasculotide is a synthetic peptide-based growth factor which targets Tie2, a receptor on specialized cells of the hematopoietic and vascular systems. Vasculotide was invented by Sunnybrook Research Institute